Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Metastatic Androgen Independent Prostate Cancer
NCT00060437Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in prostate cancer (PCa), sponsored by National Cancer Institute. Started Oct 2003; status: completed.
02
Drugs
perifosine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00060437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060437.